Brent Pfeiffenberger
About Brent Pfeiffenberger
Brent Pfeiffenberger is the SVP and Head of US Oncology at Bristol-Myers Squibb, with extensive experience in managing oncology business functions and a background in pharmacy and business administration.
Title and Current Role
Brent Pfeiffenberger currently holds the position of Senior Vice President and Head of US Oncology at Bristol-Myers Squibb. He operates out of New Jersey, United States. Since November 2019, he has been managing the oncology business functions in the United States, leveraging his extensive experience in this critical field.
Previous Experience at Rutgers University
Before his current tenure at Bristol-Myers Squibb, Brent Pfeiffenberger worked at Rutgers University. From 2001 to 2002, he served both as a Post-doctoral Fellow and as an Adjunct Faculty member in New Brunswick, New Jersey, United States. This academic role laid the groundwork for his future contributions to the pharmaceutical and healthcare industry.
Educational Background
Brent Pfeiffenberger pursued higher education with a strong focus on business and pharmacy. He earned a Master of Business Administration from The Wharton School, where he studied from 2008 to 2010. Earlier, he obtained a Doctor of Pharmacy (Pharm.D.) from Duquesne University, completing his studies from 1995 to 2001.
International Management Experience
Brent Pfeiffenberger's career includes significant international management experience, particularly in the Paris area, France. While serving as General Manager for Australia and New Zealand at Bristol-Myers Squibb, he oversaw the transition of all business functions over a seven-month period. This role underscored his capability in handling complex, multinational projects and operations.